Theralase Technologies Inc (TSV:TLT)
Price and Volume
Detailed Quote| Volume | 211,042 |
| Open | 0.1750 |
| Bid (Size) | 0.1750 (2,270) |
| Ask (Size) | 0.1800 (3,840) |
| Prev. Close | 0.1800 |
| Today's Range | 0.1750 - 0.1800 |
| 52wk Range | 0.1450 - 0.4100 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
57.3% below 52-week high
0.1750
0.1452W Low
0.4152W High
1 Week
7.9% below 1-week high
0.171W Low
0.191W High
Theralase Technologies Inc (TLT) traded between $0.14 and $0.41 over the past 52 weeks and last traded at $0.17, 57.3% below its 52-week high. Over the past week it ranged between $0.17 and $0.19.
Past 12 Months
1W
-$0.01
1M
-$0.02
3M
-$0.10
6M
-$0.08
YTD
-$0.01
1Y
-$0.03
TLT was -12.5% over the past year, -31.4% over six months, -2.8% year to date, -2.8% in the last week.
12 Months vs Market
TLT
-12.5%
DIA
+9.8%
SPY
+15.7%
QQQ
+23.7%
IWM
+13.7%
Over the past 12 months TLT returned -12.5% versus DIA (Dow) +9.8%, SPY (S&P 500) +15.7%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +13.7%.
Volume & Liquidity
0.95× 3-mo avg
Today 211,042
3-mo avg 221.6K
1W
89.5K
1M
137.4K
3M
221.6K
6M
267.0K
YTD
237.7K
1Y
218.4K
TLT most recently traded 211,042 shares against a 3-month average daily volume of 221.6K.
More News
Read More
Theralase(R) Releases Q2 2026 Financial Statements
August 28, 2026
Theralase(R) Grants Stock Options
August 07, 2026
Theralase(R) Lists Warrants on the TSXV
June 03, 2026
Theralase(R) Releases Q1 2026 Financial Statements
May 29, 2026
Theralase(R) Closes $CAN 2.66 Million Financing
April 10, 2026
Theralase(R) Closes $1.1 M Non-Brokered Private Placement
March 10, 2026
Theralase(R) Provides Update on Bladder Cancer Clinical Study
February 04, 2026
Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
February 02, 2026
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
December 23, 2025
Theralase(R) Investor Conference Call Reminder
November 17, 2025
Theralase(R) Releases 3Q2025 Financial Statements
November 10, 2025
Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug
November 03, 2025
Frequently Asked Questions
Is Theralase Technologies Inc publicly traded?
Yes, Theralase Technologies Inc is publicly traded.
What exchange does Theralase Technologies Inc trade on?
Theralase Technologies Inc trades on the Toronto Venture Stock Exchange
What is the ticker symbol for Theralase Technologies Inc?
The ticker symbol for Theralase Technologies Inc is TLT on the Toronto Venture Stock Exchange
What is the current price of Theralase Technologies Inc?
The current price of Theralase Technologies Inc is 0.1750
When was Theralase Technologies Inc last traded?
The last trade of Theralase Technologies Inc was at 10/08/26 02:45 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.